Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23457,95,1.11 [0.85-1.45],0.4398759010412497
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24098,180,0.99 [0.82-1.21],0.9581119046915352
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23863,1166,1.08 [1.00-1.17],0.0416498525656993
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Candidiasis,24126,417,1.04 [0.91-1.18],0.5618269236927296
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23375,3054,1.06 [1.01-1.11],0.0153003567552634
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23586,2490,1.05 [1.00-1.11],0.058114273371448
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23875,1179,1.08 [1.00-1.17],0.0448043665538084
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,24029,81,1.14 [0.86-1.52],0.3651388013797167
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22533,706,1.07 [0.97-1.18],0.1925834477048034
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21768,803,1.08 [0.98-1.18],0.1205601580452376
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21816,222,1.08 [0.91-1.29],0.3766253348704803
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16919,1434,1.08 [1.00-1.15],0.0390741083943578
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21619,320,1.13 [0.98-1.31],0.0941096554514275
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,24066,1370,1.05 [0.98-1.13],0.1486644810988201
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Mycoses,24180,471,1.07 [0.95-1.21],0.2428684762214137
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23525,828,1.08 [0.99-1.19],0.0787666079283821
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24134,772,1.08 [0.98-1.18],0.1276372238302151
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22876,180,1.00 [0.82-1.21],0.9851621850355184
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24238,39,0.95 [0.63-1.45],0.8291829678627887
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other septicaemia,24048,686,1.06 [0.96-1.17],0.2249146004996344
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,24022,74,0.96 [0.71-1.30],0.7826147544692119
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24154,169,1.28 [1.05-1.56],0.0136650298194192
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24139,154,1.26 [1.03-1.55],0.0271230867683484
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22993,296,1.13 [0.97-1.31],0.1074146194142954
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22923,226,1.05 [0.89-1.25],0.5549425539752832
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22798,102,1.22 [0.95-1.57],0.1183534786884832
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24216,35,1.17 [0.76-1.80],0.4768905622659892
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24169,143,1.01 [0.81-1.25],0.9465254837600878
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Viral warts,24069,43,1.25 [0.85-1.85],0.2586148041364169
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],24097,71,1.01 [0.74-1.37],0.968067287130668
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign lipomatous neoplasm,23991,209,1.11 [0.93-1.33],0.2420523712218664
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24145,62,1.14 [0.82-1.58],0.4282206756557597
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24138,60,1.47 [1.06-2.03],0.0205514884301234
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23980,1070,1.00 [0.92-1.08],0.918166192137276
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm of meninges,24213,75,1.27 [0.94-1.70],0.1193462850497475
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24177,60,1.20 [0.86-1.67],0.2862479430115932
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24206,115,1.17 [0.92-1.48],0.2094369053969885
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm of ovary,24167,150,1.14 [0.92-1.41],0.2235637413760574
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24218,243,0.90 [0.76-1.06],0.2034406939183288
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Caecum,24224,224,0.90 [0.76-1.08],0.2590340341925436
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24158,60,0.77 [0.55-1.09],0.1449619151423727
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Descending colon,24222,133,0.77 [0.61-0.97],0.0287896137964745
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Rectum,24183,245,1.05 [0.88-1.24],0.5988050084820192
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24136,450,0.97 [0.86-1.10],0.6628797000211215
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24223,256,0.94 [0.80-1.11],0.4903230949655803
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Carcinoma in situ of breast,19605,119,0.80 [0.62-1.03],0.0794884900470566
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19678,139,0.97 [0.78-1.22],0.8184786899121557
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19671,31,0.79 [0.49-1.30],0.3563883799591335
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19697,57,1.07 [0.76-1.51],0.7060404383713516
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24175,127,0.87 [0.68-1.10],0.2371120870952715
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Haemangioma, any site",24176,125,0.87 [0.69-1.11],0.257385050555714
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Leiomyoma of uterus,23354,511,0.96 [0.85-1.08],0.4636085189157627
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Lung cancer and mesothelioma,17405,288,0.93 [0.79-1.10],0.396730348881204
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Lymphoid leukaemia,19675,35,0.78 [0.49-1.23],0.2870137108541963
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19794,154,1.07 [0.87-1.32],0.5346358891963696
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19739,99,1.02 [0.78-1.33],0.8822276044614626
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19809,169,0.87 [0.71-1.07],0.1824415097180401
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19703,63,1.22 [0.88-1.69],0.2228572909670819
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19704,64,1.26 [0.91-1.74],0.1575438437682393
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19689,49,0.89 [0.61-1.30],0.535253065427814
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19769,129,1.13 [0.90-1.43],0.2832758254008002
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19734,94,1.02 [0.78-1.33],0.9029839475663892
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19715,75,1.01 [0.74-1.37],0.957071064633863
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19676,36,1.21 [0.79-1.86],0.3814008963038184
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19711,71,0.70 [0.51-0.97],0.033897394111268
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Melanocytic naevi,24003,207,1.27 [1.06-1.52],0.0082514830245346
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Melanocytic naevi of trunk,24198,70,1.31 [0.97-1.78],0.081613844705925
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Melanoma in situ,19669,77,1.20 [0.89-1.61],0.2300561335145712
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19712,72,1.10 [0.81-1.49],0.5554476196474554
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19775,135,1.17 [0.94-1.46],0.1661930283807215
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19850,210,0.80 [0.67-0.96],0.0151271718791663
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19723,83,1.36 [1.03-1.80],0.0306164414172518
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Other benign neoplasms of skin,24040,154,0.98 [0.79-1.21],0.8471931536803776
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20457,817,0.93 [0.85-1.03],0.1553586150639941
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20493,853,0.94 [0.86-1.03],0.2198767012127561
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23953,343,1.00 [0.87-1.16],0.9706527693908232
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22477,86,1.02 [0.77-1.35],0.8954105428854334
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23681,71,1.23 [0.91-1.67],0.1745154148548121
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23341,2607,1.10 [1.04-1.16],0.0002973600364621
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22812,28,1.20 [0.74-1.95],0.4552081315303545
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23887,46,1.50 [1.04-2.16],0.0316142260018881
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23722,1331,1.09 [1.02-1.18],0.0130560244746913
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23722,1331,1.09 [1.02-1.18],0.0130560244746913
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22458,67,1.03 [0.75-1.42],0.8635254953571619
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23871,1087,1.18 [1.09-1.27],4.011644404232458e-05
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23943,102,1.01 [0.78-1.30],0.9693244705476044
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23656,46,0.86 [0.58-1.28],0.46418179173
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23664,54,1.08 [0.76-1.54],0.6527455149661746
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,24050,209,1.02 [0.85-1.22],0.8310919981865776
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24141,53,1.38 [0.98-1.95],0.0684473642024743
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",24019,178,0.79 [0.65-0.97],0.0239056924301934
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22898,114,1.24 [0.97-1.57],0.0805297791906987
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,19550,212,1.01 [0.84-1.21],0.9337230592404512
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22980,60,1.02 [0.72-1.45],0.9114043268497592
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22977,57,1.39 [0.97-1.99],0.0751092318678736
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,19381,43,1.40 [0.95-2.05],0.0886402821965027
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22231,55,1.07 [0.75-1.51],0.7104507868788417
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21939,207,0.86 [0.72-1.04],0.1130632425030455
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23850,421,0.92 [0.81-1.05],0.2066650541900726
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23690,261,0.94 [0.80-1.11],0.4584852430947238
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23489,60,1.04 [0.74-1.46],0.8097638167634721
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23897,1721,1.04 [0.98-1.11],0.1773286618554849
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21497,1684,1.06 [0.99-1.13],0.0952951317291761
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",19385,47,1.33 [0.91-1.93],0.1359959164652875
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21549,103,1.05 [0.81-1.36],0.6973505833300341
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19590,252,1.12 [0.95-1.32],0.1698741406009973
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,19381,43,1.15 [0.78-1.71],0.4815952192369486
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22099,2761,1.09 [1.04-1.15],0.000370956946003
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,19524,186,1.00 [0.82-1.21],0.9926109006859148
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19822,484,1.07 [0.95-1.21],0.2419134839470911
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24149,314,1.28 [1.11-1.48],0.0006461135511049
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23981,146,1.34 [1.08-1.65],0.006476859068489
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,19429,91,1.01 [0.77-1.33],0.9461263871660353
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",19387,49,1.20 [0.83-1.74],0.3280641993806534
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23466,2020,1.04 [0.98-1.10],0.1810174524698028
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,19516,178,0.96 [0.79-1.17],0.6610782538415445
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,19511,173,1.11 [0.91-1.35],0.3165966901893053
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19806,468,1.06 [0.94-1.20],0.3135056195155083
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,19409,71,1.06 [0.78-1.45],0.6995804020347286
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23975,140,1.29 [1.04-1.60],0.019806285106229
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19880,542,0.98 [0.88-1.10],0.7718898093217879
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19824,486,1.04 [0.92-1.17],0.5346126880702146
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21796,64,1.04 [0.75-1.44],0.8074834410357077
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23464,4126,1.08 [1.04-1.13],0.0001232373159359
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21512,66,0.86 [0.62-1.19],0.3632722642639934
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21525,79,0.99 [0.74-1.33],0.942162586622544
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,24068,1804,0.99 [0.93-1.05],0.7264789048472169
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",24072,1803,0.99 [0.93-1.05],0.7494785778597015
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21519,73,1.02 [0.76-1.39],0.8765406122349809
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23874,1394,1.08 [1.01-1.16],0.0316101926053883
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20648,1310,1.04 [0.97-1.12],0.2854330607410086
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24227,157,1.02 [0.83-1.25],0.8664479540983593
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23469,40,1.02 [0.67-1.53],0.9435529031657371
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22600,120,1.02 [0.80-1.29],0.8752129537093793
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22651,171,1.07 [0.87-1.30],0.5283267423473154
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19555,217,1.25 [1.05-1.48],0.0137577913364839
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22620,121,1.01 [0.80-1.27],0.9483791508230094
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1511,38,0.74 [0.48-1.14],0.1763035290232936
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1606,152,1.06 [0.87-1.31],0.5520043812776206
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22523,24,1.45 [0.87-2.42],0.1560592725855638
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1495,23,0.89 [0.52-1.53],0.6802920670886959
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23816,1317,1.06 [0.99-1.14],0.0958284691106586
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23723,294,0.91 [0.78-1.06],0.2322467391478155
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22153,421,1.06 [0.94-1.20],0.3561993632148557
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19966,628,1.08 [0.98-1.20],0.1284071309491129
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24149,208,0.76 [0.63-0.91],0.0032962393845421
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23335,45,1.04 [0.71-1.53],0.8284903827142448
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Angina pectoris,22892,762,1.11 [1.01-1.21],0.036023631247363
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23371,81,0.93 [0.70-1.25],0.641518947350882
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23320,30,1.00 [0.62-1.62],0.9841425271319302
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23429,139,0.96 [0.77-1.20],0.7399250254569383
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15743,1279,1.02 [0.94-1.09],0.6637162544387134
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,AV-block,21261,213,1.09 [0.91-1.30],0.3653473315520187
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24196,266,0.82 [0.69-0.96],0.0168006700023351
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Cardiac arrest,14573,109,1.21 [0.94-1.54],0.1395907152806894
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21167,119,0.75 [0.58-0.96],0.021900271748615
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21119,71,1.01 [0.74-1.37],0.9722008102767962
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24234,28,1.01 [0.61-1.66],0.9718368247166372
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Conduction disorders,21688,640,1.05 [0.95-1.17],0.3402294905356053
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23429,1309,1.09 [1.01-1.17],0.0245289505680633
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21810,6424,1.04 [1.01-1.08],0.0139837123709457
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22920,221,0.81 [0.68-0.97],0.0220884607111933
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Endocarditis,21095,47,0.98 [0.67-1.45],0.9384381974337512
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24154,733,1.10 [1.00-1.21],0.0613257346263788
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Hypertension,22361,5404,1.04 [1.00-1.08],0.0414535343112265
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22369,5412,1.04 [1.00-1.07],0.0419198125045487
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24133,37,0.73 [0.47-1.14],0.1676694231682342
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",17112,155,0.97 [0.79-1.20],0.7998567777945534
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,17024,67,1.23 [0.91-1.68],0.1817345017715599
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Hypotension,24118,933,0.98 [0.90-1.06],0.5794671743025631
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23568,85,1.03 [0.78-1.37],0.8237472194107068
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23611,1481,1.10 [1.03-1.18],0.0051424260914239
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23959,403,1.02 [0.90-1.16],0.7478011056870699
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21318,270,1.01 [0.86-1.18],0.9410099380022096
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,24044,535,1.11 [0.99-1.24],0.0711812596161475
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22558,428,1.17 [1.04-1.33],0.0115514879572576
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24213,77,1.43 [1.08-1.91],0.0132963940386006
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24230,211,1.17 [0.98-1.40],0.0787560537061412
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Oesophageal varices,22734,35,0.90 [0.57-1.41],0.6395555623689697
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other aneurysm,23339,49,0.79 [0.53-1.16],0.2203441075013136
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other arrhythmias,21366,318,1.07 [0.92-1.24],0.3780023092789583
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23351,61,1.23 [0.89-1.70],0.2196131304757156
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23464,174,0.89 [0.73-1.09],0.27085183233979
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21196,148,1.02 [0.82-1.27],0.8422611919497492
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other disorders of veins,22775,76,1.14 [0.85-1.53],0.3820261004609722
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22741,42,1.10 [0.74-1.65],0.6294380114812836
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23136,32,0.66 [0.41-1.07],0.0915453349635524
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22836,137,0.97 [0.78-1.22],0.8127188202697399
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21729,681,1.00 [0.91-1.11],0.9712705077274938
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23223,38,0.71 [0.46-1.09],0.1197153951783981
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23740,450,0.92 [0.81-1.04],0.2022925491464016
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23723,292,0.96 [0.82-1.12],0.590579764632331
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23575,471,0.97 [0.86-1.09],0.5935994919156684
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14716,252,1.05 [0.89-1.24],0.5454493870687049
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23524,245,0.93 [0.78-1.10],0.3746168544770514
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22988,289,0.90 [0.77-1.06],0.2074247242606502
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23822,391,1.01 [0.89-1.15],0.8565785045128133
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24165,506,1.00 [0.89-1.13],0.9388711045068456
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21237,189,1.07 [0.89-1.30],0.4668226319871268
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23716,285,0.97 [0.83-1.14],0.7249182504026912
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23239,135,0.87 [0.69-1.10],0.2405252749644423
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23950,467,1.02 [0.90-1.15],0.7476843121924912
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23926,509,1.01 [0.90-1.13],0.857374133621544
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23537,64,1.05 [0.76-1.45],0.7594447380107788
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23326,36,1.19 [0.77-1.83],0.4270914985368683
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23744,188,1.16 [0.96-1.40],0.1145306405742742
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23687,178,1.06 [0.87-1.28],0.5858707453926206
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Varicose veins,23086,387,1.05 [0.92-1.20],0.4633105863653937
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23299,83,0.92 [0.69-1.22],0.55208153974392
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Venous thromboembolism,24050,617,0.98 [0.88-1.08],0.6525641546039614
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24200,199,1.02 [0.85-1.23],0.8264784106790246
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21552,1627,1.07 [1.00-1.14],0.0409733047007401
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,Any mental disorder,23710,3785,1.04 [1.00-1.09],0.0466794847723307
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24174,237,1.00 [0.85-1.19],0.9620998216442448
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21665,1740,1.06 [0.99-1.13],0.0830623208091959
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20003,78,1.03 [0.77-1.39],0.8289259703951626
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,Smoking dependency,23875,1049,1.05 [0.96-1.14],0.2949171186139941
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21143,1218,1.03 [0.95-1.11],0.4537000729676005
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,Vascular dementia,23811,94,0.98 [0.75-1.29],0.8835733264552814
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Alzheimer disease,24236,322,0.95 [0.82-1.10],0.4820348898178123
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",16610,51,1.02 [0.71-1.49],0.901585817959668
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Bell's palsy,22344,71,1.01 [0.74-1.38],0.9457906562739716
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22832,559,1.01 [0.90-1.13],0.8842345395069662
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Cerebral cysts,23886,191,1.06 [0.88-1.28],0.5666779006066807
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24170,240,0.94 [0.79-1.11],0.4545799902021741
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23814,38,0.83 [0.54-1.28],0.3990505821172205
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24225,44,1.53 [1.05-2.22],0.0270025382776686
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23740,45,0.91 [0.61-1.35],0.6379546616261877
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Epilepsy,22953,247,0.90 [0.76-1.07],0.2397636471154842
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23866,1160,1.02 [0.95-1.11],0.549290780415693
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24193,309,1.08 [0.93-1.25],0.3193299182651601
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23690,2539,0.95 [0.90-1.00],0.0609470314491697
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Generalized epilepsy,23914,41,1.33 [0.89-1.97],0.1592772363752022
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Hemiplegia,24122,192,0.98 [0.81-1.18],0.8165980691204335
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Hydrocephalus,23751,56,1.14 [0.81-1.61],0.4508203263569759
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24218,67,1.23 [0.90-1.68],0.1960224099926368
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22386,113,0.96 [0.75-1.23],0.7620335531779112
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22327,54,1.20 [0.85-1.69],0.3111997030120089
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Memory loss,23699,95,1.08 [0.83-1.41],0.5775795147921462
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Migraine,23147,441,1.05 [0.92-1.19],0.4668185604505527
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24135,399,1.03 [0.91-1.18],0.6096886696469989
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Motor neuron disease,16700,116,0.96 [0.75-1.23],0.748504198757775
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,24034,129,0.97 [0.77-1.22],0.7826278854706874
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23501,1228,1.03 [0.95-1.11],0.4589346273358348
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Neurological diseases,22810,3259,1.02 [0.97-1.06],0.5035610850148037
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23900,124,1.06 [0.84-1.34],0.6181862822214117
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22650,377,1.05 [0.92-1.20],0.4420887741304696
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24185,199,1.01 [0.84-1.21],0.9422345001937386
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19606,581,0.96 [0.86-1.07],0.4325361083998689
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23755,60,1.09 [0.78-1.52],0.6194258562117461
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23806,111,0.80 [0.62-1.04],0.090922846821158
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,24026,142,1.16 [0.94-1.44],0.1705534453177228
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22352,79,1.02 [0.76-1.37],0.8734031438298027
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other headache syndromes,22772,66,1.14 [0.83-1.56],0.4286021412698705
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other neurological diseases,24136,441,1.03 [0.91-1.16],0.6697820077533378
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other sleep disorders,23057,351,0.99 [0.86-1.13],0.8384144508948614
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Parkinson's disease,24213,146,1.00 [0.80-1.25],0.9923960088251416
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23768,73,1.15 [0.85-1.56],0.3641552355041894
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Restless leg syndrome,24235,76,0.96 [0.71-1.30],0.7999278994624308
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Sleep apnoea,24080,281,1.00 [0.86-1.16],0.9743438729356978
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Small fibre neuropathy,24020,34,1.23 [0.79-1.90],0.3540056215927466
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24226,140,0.87 [0.70-1.09],0.2313410747691097
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22335,62,0.96 [0.69-1.34],0.8061151747614864
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24236,325,0.96 [0.83-1.11],0.5667379927614797
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23772,91,0.97 [0.74-1.29],0.8570140250270815
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23717,94,0.87 [0.66-1.15],0.3297522563929299
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23834,427,0.99 [0.87-1.13],0.8873875472843772
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24109,143,1.00 [0.81-1.24],0.9996560011740236
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23258,53,1.08 [0.75-1.55],0.6744701619043906
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23253,48,1.24 [0.86-1.80],0.2546843590140684
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",24125,58,1.39 [1.00-1.93],0.0535445253630693
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23982,147,1.01 [0.82-1.26],0.9022824306468838
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1502,29,1.00 [0.62-1.60],0.9936496151213434
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1795,56,0.74 [0.52-1.06],0.1010706585357952
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23707,84,0.88 [0.66-1.18],0.4069348728634991
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,24086,927,1.06 [0.97-1.15],0.1852898561576428
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23863,658,1.02 [0.92-1.13],0.7094519731957354
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23471,266,1.08 [0.92-1.27],0.3542583967011957
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24161,754,1.00 [0.91-1.10],0.984435827980098
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24225,63,1.09 [0.78-1.51],0.614155234489183
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,24093,686,1.00 [0.91-1.11],0.990573438170105
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24197,362,1.00 [0.87-1.15],0.9803644455039624
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24151,185,0.87 [0.71-1.06],0.1549069003868131
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23243,38,1.15 [0.75-1.76],0.5103888175183038
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23248,43,1.36 [0.93-1.99],0.1181201804880411
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23266,61,1.11 [0.79-1.55],0.5453424752501939
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24157,627,0.98 [0.88-1.08],0.6555875364425465
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23684,154,0.91 [0.74-1.13],0.4130755056342856
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23465,58,1.03 [0.73-1.46],0.8548933877413425
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23926,91,1.00 [0.76-1.32],0.9983422998923204
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,24115,280,1.00 [0.85-1.17],0.977018838973274
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23591,184,0.97 [0.80-1.18],0.7408884359954091
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,24086,120,0.83 [0.65-1.06],0.1294619315688078
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23938,408,0.96 [0.84-1.10],0.5647388596535886
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23760,137,1.01 [0.81-1.26],0.94088166014295
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22654,2240,1.04 [0.98-1.10],0.2056591071106596
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,24080,245,1.01 [0.85-1.19],0.9048563231245464
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24215,144,1.03 [0.83-1.29],0.7589240893083355
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23543,338,1.04 [0.90-1.20],0.6191271557917306
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23894,59,0.99 [0.70-1.39],0.9506797671101006
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24212,50,1.14 [0.79-1.65],0.46819777911804
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23288,83,0.85 [0.63-1.14],0.2872328592176288
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23335,130,0.93 [0.74-1.18],0.5626758179036453
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23253,94,1.17 [0.90-1.53],0.2347493616462179
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23465,58,0.99 [0.70-1.39],0.9443164194051928
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23218,59,0.74 [0.52-1.06],0.0967138154567556
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23635,105,0.95 [0.74-1.23],0.7113123804514223
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23687,157,0.91 [0.73-1.12],0.3591522101256394
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23316,111,1.08 [0.85-1.39],0.5260726186535852
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23243,84,1.22 [0.92-1.61],0.1651018912657832
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23220,61,1.13 [0.81-1.57],0.4648946374140049
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22249,1835,1.00 [0.94-1.06],0.9816681589310768
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23283,78,1.22 [0.91-1.63],0.1857570246208954
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,24004,381,0.95 [0.83-1.09],0.4741630048075854
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23663,40,0.84 [0.55-1.28],0.412591901754774
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23771,148,1.04 [0.84-1.29],0.7362309606365149
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,24008,102,0.78 [0.59-1.01],0.063042324901061
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24194,95,0.87 [0.66-1.14],0.2990067819766071
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,24125,128,1.03 [0.82-1.30],0.8137372869744876
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23971,65,1.12 [0.81-1.54],0.5024938744143759
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23973,67,0.93 [0.67-1.28],0.6499907007273584
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,24141,707,1.01 [0.92-1.11],0.8417052722005324
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23917,483,1.07 [0.95-1.21],0.2411469022800711
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23535,101,0.85 [0.65-1.11],0.2378293303809756
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23511,77,1.14 [0.85-1.54],0.3689278420748594
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Acute pharyngitis,23986,75,0.74 [0.54-1.01],0.0558315896726238
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24122,211,0.86 [0.72-1.04],0.1130905304554123
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23969,58,0.97 [0.69-1.37],0.8700300940445782
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,All influenza,22735,114,1.05 [0.82-1.34],0.6824371885078859
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22734,113,1.07 [0.84-1.37],0.594078391202711
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17231,114,1.20 [0.94-1.53],0.1343875862682953
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Allergic rhinitis,24113,250,1.23 [1.05-1.45],0.0116260561099197
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18800,1845,1.07 [1.01-1.14],0.0259131549495031
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18938,1821,1.07 [1.00-1.14],0.0380246362721863
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23872,116,1.16 [0.91-1.47],0.2297053077437184
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22683,62,1.27 [0.92-1.76],0.1492177102510082
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Bronchiectasis,20934,356,1.35 [1.18-1.55],1.2108423228362407e-05
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20640,62,1.00 [0.72-1.40],0.9825966344951632
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23214,2636,1.09 [1.04-1.15],0.0009668722008591
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",23109,58,1.00 [0.70-1.41],0.9840127301842524
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Chronic sinusitis,23179,128,1.19 [0.95-1.49],0.1349869657786926
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",24082,913,1.08 [0.99-1.17],0.0834437646939967
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Deviated nasal septum,23118,67,1.17 [0.86-1.61],0.3165222416256828
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22378,4538,1.09 [1.05-1.13],1.2330041595155674e-05
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23351,300,1.10 [0.95-1.28],0.1995926724227341
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Early onset COPD,23454,285,1.09 [0.93-1.28],0.2655596906403901
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Emphysema,20812,234,1.29 [1.09-1.53],0.0025976270254411
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22747,207,1.01 [0.85-1.21],0.8897034339076987
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Influenza and pneumonia,24056,1435,1.07 [1.00-1.14],0.0667649463727342
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Interstitial lung disease,22784,244,1.04 [0.88-1.22],0.6824677602958643
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Later onset COPD,23410,628,1.08 [0.98-1.20],0.1347074680962326
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24230,192,1.03 [0.85-1.24],0.7670789431573286
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Nasal polyp,23112,61,1.00 [0.72-1.40],0.9818389447520346
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,24028,827,1.06 [0.96-1.16],0.2409041634542128
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other diseases of pleura,24065,1539,1.08 [1.01-1.15],0.0223023246187831
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23747,696,1.19 [1.08-1.31],0.0004278862439642
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other pleural conditions,22561,35,0.85 [0.54-1.33],0.4672126341254633
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24160,308,1.00 [0.86-1.16],0.964661750117778
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24155,1049,1.10 [1.02-1.19],0.0197359232395392
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pleural effusion,23258,732,1.08 [0.98-1.18],0.1362172536654438
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pleural plaque,22567,41,1.19 [0.80-1.78],0.3975937301758149
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23840,1219,1.06 [0.98-1.14],0.1424943383320619
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24202,164,1.01 [0.82-1.23],0.9581525825446252
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pneumothorax,22614,88,1.10 [0.83-1.45],0.4962283272892119
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pollen allergy,24216,211,1.19 [1.00-1.42],0.0518365259086111
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pulmonary oedema,23906,54,0.77 [0.54-1.10],0.1549472438065906
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17161,44,1.42 [0.97-2.08],0.0726251108049134
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,24009,808,1.04 [0.95-1.14],0.3590198038765608
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23301,250,1.24 [1.05-1.46],0.0097084474845436
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Viral pneumonia,22807,186,1.04 [0.85-1.25],0.7214461979483136
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23879,146,0.99 [0.80-1.23],0.9313717864497048
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11682,91,1.15 [0.87-1.51],0.3320888783001441
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,17342,35,1.10 [0.71-1.70],0.6786919859464811
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Acute appendicitis,24063,123,0.77 [0.60-0.98],0.0345224988321854
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Acute gastritis,18198,74,0.99 [0.72-1.34],0.924378073606228
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Acute pancreatitis,22212,143,1.31 [1.06-1.61],0.0134333963331797
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Acute peritonitis,23725,74,1.31 [0.97-1.76],0.0741436325570894
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23470,33,1.08 [0.69-1.71],0.7249850541022036
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Barrett oesophagus,18432,308,1.04 [0.90-1.21],0.585586770585768
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22142,73,1.47 [1.09-1.97],0.010513451819385
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23860,73,1.47 [1.10-1.97],0.0101856838883925
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Cholecystitis,22227,158,1.04 [0.85-1.28],0.7047944596982706
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Cholelithiasis,23126,1057,1.03 [0.95-1.12],0.4301313485956892
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Chronic gastritis,18420,296,1.18 [1.01-1.37],0.0345056863233031
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22105,36,1.15 [0.75-1.78],0.51548736193337
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24164,68,0.99 [0.72-1.36],0.959649693724447
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Coeliac disease,22883,128,1.06 [0.84-1.33],0.6358245425101978
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Collagenous colitis,22557,95,0.97 [0.74-1.27],0.8057766482230387
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24111,142,1.08 [0.86-1.34],0.5150536966474768
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Constipation,23939,1494,1.01 [0.94-1.08],0.8229282797358008
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Crohn disease,22536,74,1.18 [0.88-1.60],0.2742998657730197
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23912,51,1.20 [0.84-1.72],0.3240068262484848
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22538,76,1.12 [0.83-1.51],0.4456253499378813
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Dental caries,23506,203,1.02 [0.85-1.23],0.8163656914222372
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22787,2147,1.00 [0.95-1.06],0.8677736235054904
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of appendix,24102,162,0.94 [0.76-1.16],0.5698772649033197
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of liver,24148,711,1.07 [0.97-1.18],0.187493373030479
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22201,4077,1.02 [0.98-1.06],0.3374726832787901
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23823,520,1.04 [0.93-1.17],0.5046992837070159
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24125,474,1.16 [1.03-1.30],0.0140978046219109
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23407,104,0.95 [0.73-1.23],0.6774221258845381
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23277,57,1.16 [0.83-1.64],0.3833243458214398
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23976,1221,1.02 [0.94-1.09],0.6927892732569334
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of tongue,23279,93,1.08 [0.82-1.41],0.5771357879826644
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23479,1410,1.07 [1.00-1.14],0.0681228764283029
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20128,2821,1.04 [0.99-1.10],0.0911686876500432
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Duodenal ulcer,18243,119,1.08 [0.85-1.37],0.5305371500750775
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24187,99,1.02 [0.79-1.33],0.8636423817809955
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24151,57,1.44 [1.03-2.01],0.0317717377122703
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23522,85,1.04 [0.78-1.38],0.7967017462112513
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17411,104,1.17 [0.91-1.50],0.2272928574120288
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Functional dyspepsia,18712,588,1.05 [0.94-1.17],0.3549972793486701
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Gastric ulcer,18433,309,0.95 [0.82-1.11],0.5111023784061177
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20578,2454,1.04 [0.99-1.10],0.1186022192682732
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18548,424,0.98 [0.86-1.11],0.7321166241403997
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18953,7415,1.04 [1.01-1.07],0.0177209758051585
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,GI-bleeding,23730,975,1.01 [0.93-1.10],0.7931176579683314
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23364,61,1.04 [0.75-1.46],0.8018474029717013
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,18164,1116,1.09 [1.01-1.18],0.0319319967893252
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23471,34,0.81 [0.51-1.28],0.371248763666962
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Hernia,23178,2538,0.99 [0.94-1.05],0.7734639272660456
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Impacted teeth,24159,52,1.65 [1.17-2.33],0.0042000790218186
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Impaction of intestines,17366,59,1.21 [0.87-1.69],0.2636065345327734
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Inguinal hernia,20794,154,0.86 [0.69-1.07],0.1714085728789598
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,17393,86,0.95 [0.71-1.26],0.7010364316545814
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22910,155,1.06 [0.86-1.31],0.5872973512530799
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18020,713,1.07 [0.97-1.18],0.1612905643677022
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24225,306,1.22 [1.06-1.42],0.0066079803062064
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23185,723,1.13 [1.02-1.24],0.0144506113880073
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23427,965,1.14 [1.05-1.23],0.0026671666603427
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18258,134,1.19 [0.95-1.49],0.125025121554232
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Oesophagitis,18634,510,1.04 [0.92-1.16],0.5432800290992114
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24194,142,1.13 [0.91-1.40],0.2700899264386724
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20694,54,1.02 [0.72-1.45],0.9136043886116338
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18415,1108,1.02 [0.95-1.11],0.5478193911547762
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22332,263,1.06 [0.90-1.24],0.5024506284045103
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22236,167,0.90 [0.74-1.11],0.3220771368572157
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of intestine,18701,1394,0.98 [0.91-1.05],0.5391469001504154
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of intestines,22319,5012,1.02 [0.98-1.06],0.370207993298192
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23278,205,1.07 [0.90-1.29],0.440032692737059
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of liver,24028,591,1.07 [0.97-1.20],0.186635938376857
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18653,529,0.99 [0.89-1.12],0.9307506423902014
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22206,137,0.97 [0.77-1.21],0.7574006935295218
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,24068,417,1.13 [0.99-1.28],0.0622660335947275
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19075,951,1.00 [0.91-1.08],0.9276656076002356
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23746,991,1.01 [0.93-1.10],0.8124240639351064
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23459,156,1.03 [0.83-1.27],0.7887525365690358
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18853,1546,1.02 [0.95-1.09],0.5752965517568707
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19973,1849,0.96 [0.91-1.02],0.228419047729468
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23530,93,1.02 [0.78-1.34],0.8697990156162269
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23315,853,1.10 [1.00-1.20],0.0444188185700542
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17601,294,1.07 [0.92-1.25],0.3843714466443083
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24142,66,1.39 [1.02-1.89],0.039884251023877
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17743,436,1.02 [0.90-1.15],0.7812891019894515
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22877,122,0.98 [0.77-1.24],0.8383550628536512
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24228,65,0.88 [0.63-1.22],0.4385607930164044
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23305,118,0.91 [0.72-1.17],0.4737573790319281
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Toxic colitis,22517,55,0.93 [0.65-1.33],0.7042217714569046
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18335,211,1.14 [0.95-1.37],0.1487658984589939
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Ulcerative colitis,22613,151,1.44 [1.17-1.76],0.000539641071402
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22590,128,1.46 [1.17-1.82],0.0008814119101362
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Umbilical hernia,20794,154,0.82 [0.66-1.02],0.0737058154649626
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,17476,169,0.99 [0.81-1.21],0.913160077775486
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Ventral hernia,20864,224,1.04 [0.87-1.24],0.6491625692260415
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Volvulus,17381,74,0.81 [0.59-1.10],0.1817255195930332
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24161,221,1.22 [1.03-1.45],0.0225304552693555
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23950,76,0.81 [0.59-1.10],0.1718127673069109
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22412,196,0.98 [0.82-1.19],0.8730250644580246
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23756,554,1.02 [0.91-1.14],0.7097552843656403
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23336,134,1.04 [0.83-1.30],0.7362763880908219
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22501,285,0.88 [0.76-1.04],0.1279174960673672
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23955,249,1.11 [0.95-1.31],0.1949122262685909
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24136,430,1.00 [0.88-1.14],0.9779315501277558
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23752,46,0.89 [0.60-1.31],0.5534287575701577
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22819,2804,1.01 [0.96-1.06],0.6664178011897722
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23838,413,0.89 [0.78-1.02],0.0873168851622303
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23709,284,0.92 [0.78-1.07],0.2881429567864418
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23950,748,1.02 [0.92-1.12],0.758617567344448
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24217,68,1.06 [0.77-1.46],0.7149257586975157
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22304,88,0.75 [0.56-1.00],0.0477184002855387
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23464,39,1.12 [0.74-1.70],0.5773374538134681
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23941,235,1.11 [0.94-1.31],0.2331426221930001
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22591,375,1.10 [0.96-1.26],0.1594665153473858
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22264,48,1.10 [0.76-1.60],0.6143833809405771
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,24144,69,0.69 [0.50-0.96],0.0257986186381922
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23336,134,1.22 [0.98-1.53],0.0741277723321197
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,24025,151,0.72 [0.58-0.89],0.0030939205986584
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23750,44,0.88 [0.59-1.30],0.5129410502914917
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22274,58,0.91 [0.64-1.29],0.5961828658968501
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23635,1419,1.02 [0.95-1.09],0.6373382378285828
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22622,406,1.11 [0.97-1.26],0.1208020421492207
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22268,52,1.13 [0.79-1.62],0.5112062680125788
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24159,285,0.84 [0.72-0.99],0.0359106747404317
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23781,75,0.69 [0.50-0.94],0.0199476278431223
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24094,220,0.79 [0.66-0.95],0.0121248366105059
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24188,248,1.18 [1.00-1.39],0.050563569286418
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22358,142,1.04 [0.84-1.30],0.7079798435813006
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22450,234,1.05 [0.88-1.25],0.5778060776308416
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24176,236,1.17 [0.99-1.38],0.068852630074851
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22394,178,1.04 [0.86-1.27],0.6821569420816349
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24203,128,0.81 [0.64-1.03],0.0843626894799376
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20688,119,1.16 [0.91-1.47],0.2230015104612591
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22014,5643,0.99 [0.96-1.03],0.7784025880944994
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20780,4409,1.01 [0.97-1.05],0.7639660169791755
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20635,66,0.93 [0.67-1.28],0.6541910727562088
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20789,139,1.06 [0.85-1.33],0.5861546288504873
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20835,185,1.02 [0.84-1.24],0.8086567161145102
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23984,102,0.80 [0.61-1.04],0.0966532944667754
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20754,104,1.01 [0.78-1.31],0.916358552201878
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17592,1221,0.98 [0.91-1.06],0.6872167298312333
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24095,201,0.92 [0.76-1.10],0.3571590823564283
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21169,519,1.06 [0.94-1.19],0.3249693021518126
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20368,7194,1.00 [0.97-1.03],0.8751863556607561
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21702,124,1.14 [0.90-1.43],0.2831179985374903
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20690,121,1.15 [0.91-1.45],0.255483474970997
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21179,610,1.01 [0.91-1.12],0.844915377880574
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23327,2677,1.04 [0.99-1.10],0.1003555215659063
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20727,158,0.97 [0.79-1.20],0.7934454288909973
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20913,344,1.21 [1.05-1.39],0.0076884604090663
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20724,155,1.14 [0.92-1.40],0.2277991965322758
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23358,93,0.93 [0.71-1.23],0.6181935807996228
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18029,1658,1.02 [0.96-1.09],0.5151477736693149
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16555,184,1.17 [0.96-1.41],0.1129004217779594
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24223,181,1.10 [0.91-1.33],0.3264464124012239
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16466,95,1.15 [0.88-1.50],0.3198630582177278
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16883,512,0.89 [0.79-1.00],0.0543178618943568
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20868,299,0.94 [0.81-1.10],0.4358409231448352
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16927,556,0.97 [0.87-1.09],0.5987477743086336
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20709,59,1.15 [0.82-1.60],0.4278968980704081
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21284,634,1.10 [0.99-1.22],0.0793477912443973
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20946,296,1.02 [0.88-1.19],0.8008472120713417
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16888,517,0.99 [0.88-1.11],0.8029627148860135
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20643,74,1.24 [0.92-1.66],0.161989452335193
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20631,62,1.05 [0.75-1.46],0.7796079469901818
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21624,46,1.16 [0.79-1.70],0.4392510453097159
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23819,2241,1.00 [0.95-1.06],0.8803675939851712
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23191,1613,1.00 [0.94-1.07],0.959045948748286
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",24051,526,1.14 [1.02-1.28],0.0203282483449393
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19063,2692,1.02 [0.97-1.07],0.4628407657492321
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16432,61,0.86 [0.61-1.22],0.4062820570738795
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20661,92,1.09 [0.83-1.43],0.5305755507910517
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16413,42,1.08 [0.72-1.62],0.7276549212848265
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16554,183,1.03 [0.85-1.25],0.7531533214182657
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21841,263,0.95 [0.81-1.12],0.5466486971064834
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22084,506,0.97 [0.86-1.09],0.6248738945533895
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24212,97,1.16 [0.89-1.50],0.2698853079420309
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22454,1804,1.05 [0.99-1.11],0.1310584890458972
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20683,114,0.89 [0.69-1.14],0.3379789130769204
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16579,208,0.89 [0.74-1.07],0.2215783474287898
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21366,716,1.02 [0.93-1.13],0.6519928515531608
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18624,2253,1.00 [0.95-1.06],0.996239484466599
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23380,115,0.93 [0.72-1.19],0.5467126057109442
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24218,75,0.91 [0.67-1.23],0.5342448539922999
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20637,68,1.23 [0.90-1.68],0.1895996777285857
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21875,1306,1.05 [0.97-1.13],0.2051745182830271
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20642,73,1.25 [0.93-1.69],0.1436705578010177
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18139,1768,1.07 [1.00-1.14],0.0366277019911117
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21708,130,1.06 [0.84-1.34],0.6039462671618188
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20619,50,0.81 [0.56-1.19],0.2896145138542173
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20827,177,0.91 [0.75-1.11],0.3647540678941349
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21080,511,1.00 [0.89-1.12],0.9829092675579582
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23717,452,1.18 [1.05-1.34],0.0065067372194086
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21219,569,1.01 [0.90-1.12],0.9103894849592103
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,24063,509,1.16 [1.03-1.30],0.0121856769599746
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24211,59,1.50 [1.08-2.07],0.0151227411774202
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20766,197,0.94 [0.78-1.14],0.5444887368968048
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18583,809,1.04 [0.95-1.14],0.3506953942468809
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21160,591,0.98 [0.88-1.10],0.760807519677361
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20679,110,1.07 [0.83-1.37],0.6083651141722366
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16446,75,0.98 [0.73-1.34],0.9192068441837188
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18717,2346,1.07 [1.01-1.13],0.0163136354467623
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17111,740,1.02 [0.92-1.12],0.7470996839562931
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23525,260,1.22 [1.04-1.44],0.0132822732286465
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24186,71,1.00 [0.73-1.37],0.9942031809900196
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22214,49,1.21 [0.84-1.73],0.3140492216107249
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16447,76,0.89 [0.66-1.22],0.4767256132952058
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20750,100,1.01 [0.78-1.31],0.9558274572437974
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16901,530,1.15 [1.03-1.29],0.0136735903418192
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20855,286,0.83 [0.71-0.98],0.0233466816394802
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20904,254,1.20 [1.02-1.41],0.026823411748808
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20896,246,1.06 [0.90-1.25],0.4759059132520498
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18691,78,1.28 [0.96-1.71],0.0967032081528568
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24217,65,1.28 [0.93-1.75],0.1283467568826242
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21134,565,0.97 [0.87-1.08],0.5830059320750904
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],23412,147,1.14 [0.92-1.41],0.2310144119907644
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,23070,2501,1.03 [0.97-1.08],0.3180247196960351
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20709,140,0.84 [0.67-1.05],0.1339575591851627
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21141,491,1.09 [0.97-1.22],0.1677648172625954
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22674,230,0.92 [0.77-1.10],0.3495119637474274
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20871,221,1.08 [0.91-1.29],0.3738712943523558
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22183,1533,1.02 [0.96-1.09],0.5325918121602116
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21692,1042,1.03 [0.95-1.12],0.4683247473459464
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20626,57,0.98 [0.69-1.39],0.9136031058748002
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23482,217,0.98 [0.82-1.17],0.8380723798440771
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20746,177,0.97 [0.80-1.18],0.7703192550584713
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20687,118,0.90 [0.71-1.15],0.4023575047348072
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16417,46,1.24 [0.85-1.81],0.2683019401193066
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23379,1049,1.05 [0.97-1.14],0.2536553024714399
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18118,87,1.06 [0.80-1.40],0.6811363318993294
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23622,100,0.97 [0.74-1.26],0.8038801979082744
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,24094,201,1.27 [1.06-1.52],0.0091783525636278
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23915,22,0.93 [0.53-1.63],0.7925674937374608
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23505,1175,1.01 [0.93-1.09],0.8472154969050741
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,24092,60,0.83 [0.59-1.17],0.2952045784995535
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,24061,207,0.95 [0.79-1.14],0.5720300327545802
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Cystitis,21409,221,1.03 [0.86-1.23],0.7457576469844289
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Dialysis,22375,45,1.48 [1.02-2.15],0.0374045209883998
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23811,289,1.01 [0.87-1.18],0.8520298378099092
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Endometriosis,18182,151,1.01 [0.82-1.26],0.8920446800243673
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18376,345,0.83 [0.72-0.97],0.0157811483404564
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18912,881,1.06 [0.97-1.15],0.2237900283442144
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18825,4369,1.02 [0.98-1.06],0.2610094006260541
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24085,53,1.00 [0.70-1.43],0.9939443212763244
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22206,182,1.02 [0.84-1.24],0.8554325564802705
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23747,350,0.98 [0.85-1.12],0.7528140657475002
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Irregular menses,23824,110,0.68 [0.52-0.89],0.0043902329843954
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18301,270,0.96 [0.82-1.14],0.6638420280994117
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21256,68,1.25 [0.92-1.71],0.1522530779404966
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,20185,2154,0.98 [0.93-1.04],0.5321408641785974
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18153,122,1.04 [0.82-1.32],0.7403826954484687
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24227,57,1.28 [0.91-1.80],0.1536680298466768
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24227,72,1.01 [0.74-1.37],0.9584384069305992
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23134,1946,1.03 [0.97-1.09],0.4101841328653081
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21606,418,1.02 [0.90-1.16],0.7525290134159476
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23624,102,1.02 [0.79-1.33],0.852404811718487
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24184,330,1.08 [0.93-1.24],0.3113108899336927
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24183,79,1.17 [0.87-1.56],0.2965372568310752
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22856,1668,1.03 [0.96-1.09],0.4160512679831427
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23577,180,1.06 [0.87-1.29],0.5619406536174993
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18168,137,1.23 [0.99-1.53],0.0657408167136872
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18377,346,0.98 [0.85-1.13],0.7660728012755399
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18134,103,1.08 [0.83-1.39],0.5779551320695158
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18214,183,1.05 [0.86-1.27],0.6396483304565522
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22253,229,1.05 [0.89-1.25],0.5431441882087843
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23963,109,1.30 [1.02-1.66],0.031767954931112
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18294,263,1.04 [0.89-1.22],0.6140245437388647
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18124,93,0.92 [0.70-1.22],0.5787967083346639
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18599,568,0.97 [0.87-1.08],0.5704296933639297
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,18172,141,1.07 [0.86-1.34],0.5249590924163086
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18554,523,1.00 [0.89-1.12],0.9387678424480655
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,24066,34,1.22 [0.79-1.89],0.3682074661805363
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24079,2055,1.04 [0.98-1.10],0.2282721802956062
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22171,147,1.16 [0.94-1.44],0.1621395288634584
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22414,84,1.04 [0.78-1.38],0.7970833620888085
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23925,32,0.96 [0.60-1.52],0.8475406933613325
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21317,129,1.24 [0.99-1.55],0.0599503826739223
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Urolithiasis,24125,232,1.22 [1.04-1.45],0.0180663513939185
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Uterine polyps,18154,123,1.09 [0.87-1.38],0.4467668457166678
